Evogene Ltd Stock News

A failure in metabolite breakdown leads to their ordered self-assembly into pathological aggregates, such as in Tyrosinemia   and Gout. REHOVOT, Israel , Aug. 12, 2025 /PRNewswire/ -- Evogene Ltd.

Zoom conference call scheduled for August 19, 2025, 9:00 AM ET REHOVOT, Israel , July 29, 2025 /PRNewswire/ -- Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a leading computational biology company targeting to revolutionize life-science product discovery and development, announced today that it will release its financial results for the first quarter of 2025, on Tuesday , August 19 , 2025.

REHOVOT, Israel , July 8, 2025 /PRNewswire/ -- Evogene Ltd.  (NASDAQ: EVGN) (TASE: EVGN), a leading computational biology company utilizing cutting-edge artificial intelligence and predictive biology to drive innovation in life-science product development, today announced the successful completion and closing of the previously disclosed transaction involving the divestiture of the majority of t...

The new model addresses the challenge of identifying novel small molecules that meet multiple product criteria, an essential requirement for pharma and agriculture applications REHOVOT, Israel , June 10, 2025 /PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a leading computational biology company focused on revolutionizing life-science product discovery and development, today announced...

Evogene Ltd. (NASDAQ:EVGN ) Q1 2025 Earnings Conference Call May 21, 2025 9:00 AM ET Company Participants Ofer Haviv - President and Chief Executive Officer Yaron Eldad - Chief Financial Officer Operator Welcome to Evogene's First Quarter 2025 Results Conference Call.

Conference call and webcast: today, May 21, 2025, 9:00 am ET Financial Highlights: In the first quarter of 2025, total revenues were approximately $2.4 million, compared to approximately $4.2 million in the first quarter of 2024. The first quarter of 2024 revenues included license fee payments totaling $3.5 million - $2.5 million from Lavie Bio's license fee under its collaboration with Corteva...

Zoom conference call scheduled for May 21, 2025, 9:00 AM ET REHOVOT, Israel , May 8, 2025 /PRNewswire/ -- May 8, 2025 - Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a leading computational biology company targeting to revolutionize life-science product discovery and development, announced today that it will release its financial results for the first quarter of 2025, on Wednesday, May 21, 2025.

Lavie Bio improves agriculture productivity and sustainability through microbiome-based ag-biological products REHOVOT, Israel , April 21, 2025 /PRNewswire/ -- Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN) a leading computational biology company focused on revolutionizing life-science-based product discovery and development, today announced the signing of a definitive agreement under which ICL, will...